Early Administration of Edoxaban After Acute Ischemic Stroke in Patients With Non-valvular Atrial Fibrillation

Not yet recruiting

Phase 2 Results N/A

Summary of Purpose

The investigators hypothesize that earlier initiation of edoxaban in AF-related stroke patients may significantly reduce the early recurrence of ischemic stroke, compared with conventional strategy of anticoagulation following 1-3-6-12 rule. To expedite the verification of the hypothesis, the investigators are planning to use diffusion weighted imaging (DWI), which has been reported to be a surrogate to predict...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 February 2018.

31 Mar 2018 8 Feb 2018 31 May 2019 31 May 2019 1 Feb 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts

  • Jong Sung Kim, M.D.,Ph D.